Ozmosi | EPIGALLOCATECHIN-3-GALLATE Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

EPIGALLOCATECHIN-3-GALLATE

Alternative Names: epigallocatechin-3-gallate, epigallocatechin gallate, tea catechin, teavigo, green tea extract, polyphenols, sunphenon, egcg
Clinical Status: Active
Latest Update: 2025-12-02
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Proteasome Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Lo.Li.Pharma s.r.l
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for EPIGALLOCATECHIN-3-GALLATE

Countries in Clinic: Australia

Active Clinical Trial Count: 1

Recent & Upcoming Milestones

Highest Development Phases

Phase 1: COVID-19

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

ACTRN12622000284763

 ACTRN12622000284763

P1

Not yet recruiting

COVID-19

None

2024-08-29

Treatments

Recent News Events

Date

Type

Title

11/26/2025

News Article

 Forte Group Announces Corporate and Branded Product Transformation to VANTA in Strategic Rebrand Advancing Its Blackwater Ready-to-Drink Platform and Expanding Its Ecosystem of Longevity-Focused Nutraceuticals Across Canadian, U.S., and International Markets

11/25/2025

News Article

 JUNG KWAN JANG Launches Black Friday & Holiday Promotions and Introduces New Wellness Innovations for U.S. Consumers

11/21/2025

News Article

 Botanical Supplements Market Set to Surge with 10.3% CAGR, Reaching USD 145.16 Billion by 2034

11/07/2025

News Article

 Nutraceutical Ingredients Market Size Worth USD 191.04 Bn by 2034

05/15/2024

PubMed

 Influence of Silver Nanoparticles on the Metabolites of Two Transgenic Soybean Varieties: An NMR-Based Metabolomics Approach.

05/01/2024

PubMed

 Metal-phenolic network as precursor complex coating for forward osmosis membrane with enhanced antifouling property.

04/30/2024

PubMed

 Green tea extract suppresses airway inflammation via oxidative stress-driven MAPKs/MMP-9 signaling in asthmatic mice and human airway epithelial cells.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions